TABLE 4.

Sensitivity analysis including only patients with diagnoses of cardiogenic shock

	Unmatched cohorts				Matched cohorts
Variables no. (%)	Female (n = 2,594)	Male (n = 6,362)	Total (n = 8,956)	p-value	Female (n = 2,573)	Male (n = 2,402)	Total (n = 4,975)	p-value
In-hospital outcomes
Major adverse events	56.8	52	53.4	<.01	56.7	53.7	55.2	.12
Death	50.2	47.1	48	.07	50.1	48	49.1	.29
Vascular complications	3.1	1.7	2.1	.02	3.1	1.9	2.5	.06
Major bleeding	9.2	6.2	7.1	<.01	9.3	7.3	8.3	.09
Severe disability surrogates
Nonhome discharge	22.2	19.7	20.4	.20	22.4	19.7	21.1	.08
Mechanical ventilation	58.1	57.3	57.5	.95	58.1	55.8	57	.26
Resources utilization
Length of hospitalization	7	7	7	<.01	8	8	7	.047
Median days (25th-75th IQR)	2-14	3-14	2-14	–	2-15	3-16	2-14	–
Cost of hospitalization	64,208	67,960	66,743	<.01	64,274	67,994	65,722	.02
Median $ (25th–75th IQR)	(44,521–93,928)	(47,484–101,747)	(46,696–99,538)	–	(44,553–93,886)	(46,956–101,288)	(45,769–97,147)	–

Abbreviation: IQR, interquartile range.